Table 3. Suboptimal immune recovery during the first 5 years of antiretroviral therapy at seven sites in East Africa.
| Months of follow-up | Number in care with CD4+ cell counts | Number and proportion with SO-IR < 200 cells/μl n (%) | Number and proportion with SO-IR <350 cells/μl n (%) | Number and proportion with SO-IR <500 cells/μl n (%) |
|---|---|---|---|---|
| 6 | 29 050 | 10 355 (36) | 20 689 (71) | 25 907 (89) |
| 12 | 22 347 | 6376 (29) | 14 684 (66) | 19 369 (87) |
| 24 | 14 058 | 2803 (20) | 7699 (58) | 11 213 (80) |
| 36 | 6037 | 978 (16) | 2851 (47) | 4471 (74) |
| 48 | 4024 | 578 (14) | 1685 (42) | 2721 (68) |
| 60 | 2149 | 235 (11) | 813 (38) | 1355 (63) |
SO-IR, suboptimal immune recovery.